Abstract
Motivated by earlier findings that exposure to daily outdoor PM2.5 (P) may increase the risk of influenza infection, our study examines if immediate exposure to outdoor P will modify the rate of change in the daily number of COVID-19 infections (R), for (1) the high infection provincial capital cities in China and (2) Wuhan, China, using regression modelling. A multiple linear regression model was constructed to model the statistical relationship between P and R in China and in Wuhan, from 1 January to 20 March 2020. We carefully accounted for potential key confounders and addressed collinearity. The causal relationship between P and R, and the interaction effect between key variables were investigated. A causal relationship between P and R across the high infection provincial capital cities in China was established via matching. A higher P resulted in a higher R in China. A 10 µg/m3 increase in P gave a 1.5% increase in R (p < 0.001). An interaction analysis between P and absolute humidity (AH) showed a statistically significant negative relationship between P × AH and R (p < 0.05). When AH was $ 5.8 g/m3, a higher P and AH gave a higher R. In contrast, when AH ≥ 5.8 g/m3, the effect of a higher P was counteracted by the effect of a higher AH, resulting in a lower R. Given that P can exacerbate R, we recommend the installation of air purifiers and better air ventilation to reduce the effect of P on R. Further, given the increasing discussions/observations that COVID-19 can be airborne, we highly recommend the wearing of surgical masks to keep one from contracting COVID-19 via the viral-particulate transmission pathway.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is supported in part by the Theme-based Research Scheme of the Research Grants Council of Hong Kong, under Grant No. T41-709/17-N.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee approval was not required because this study used only secondary aggregated health data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# The first three authors have equal contributions.
Updated analysis for (1) the high-infection provincial capital cities in China and (2) Wuhan only.
Data Availability
The datasets are available from the corresponding authors on reasonable request.
